 Daniel Searing
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 10 | 2025 | 1797 | 0.870 |
Why?
| | Allergy and Immunology | 1 | 2020 | 43 | 0.610 |
Why?
| | Vitamin D | 3 | 2012 | 404 | 0.560 |
Why?
| | Vitamin D Deficiency | 2 | 2010 | 190 | 0.540 |
Why?
| | Betacoronavirus | 1 | 2020 | 289 | 0.500 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 391 | 0.430 |
Why?
| | Coronavirus Infections | 1 | 2020 | 384 | 0.430 |
Why?
| | Cockroaches | 2 | 2025 | 23 | 0.400 |
Why?
| | Delivery of Health Care | 1 | 2020 | 947 | 0.380 |
Why?
| | Pandemics | 1 | 2020 | 1711 | 0.340 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2010 | 25 | 0.320 |
Why?
| | Receptors, Calcitriol | 1 | 2010 | 56 | 0.310 |
Why?
| | Air Pollution | 2 | 2017 | 315 | 0.280 |
Why?
| | Dexamethasone | 2 | 2012 | 365 | 0.280 |
Why?
| | Allergens | 4 | 2025 | 386 | 0.260 |
Why?
| | Dermatitis, Atopic | 1 | 2010 | 322 | 0.250 |
Why?
| | Glucocorticoids | 1 | 2010 | 532 | 0.230 |
Why?
| | Desensitization, Immunologic | 1 | 2025 | 89 | 0.210 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2020 | 68 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1146 | 0.140 |
Why?
| | Eosinophilia | 1 | 2020 | 224 | 0.130 |
Why?
| | Anti-Asthmatic Agents | 1 | 2020 | 260 | 0.130 |
Why?
| | Environmental Exposure | 2 | 2018 | 578 | 0.120 |
Why?
| | Urban Population | 1 | 2018 | 494 | 0.110 |
Why?
| | Child | 7 | 2025 | 22739 | 0.090 |
Why?
| | Telemedicine | 1 | 2020 | 966 | 0.080 |
Why?
| | Intermediate Filament Proteins | 1 | 2010 | 57 | 0.080 |
Why?
| | Inhalation Exposure | 1 | 2011 | 103 | 0.080 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 23 | 0.080 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2010 | 81 | 0.080 |
Why?
| | Immunomodulation | 1 | 2010 | 99 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2018 | 1149 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 1 | 2012 | 484 | 0.070 |
Why?
| | Prevalence | 2 | 2018 | 2874 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2010 | 310 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2010 | 615 | 0.070 |
Why?
| | Humans | 11 | 2025 | 145763 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1043 | 0.060 |
Why?
| | Air Pollutants | 1 | 2011 | 406 | 0.060 |
Why?
| | Lymphocyte Activation | 1 | 2010 | 1133 | 0.060 |
Why?
| | Immunoglobulin E | 2 | 2020 | 315 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 574 | 0.050 |
Why?
| | Lung | 2 | 2017 | 4116 | 0.050 |
Why?
| | Epigenesis, Genetic | 2 | 2018 | 693 | 0.050 |
Why?
| | Animals | 4 | 2025 | 38097 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1997 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2399 | 0.040 |
Why?
| | Nasal Provocation Tests | 1 | 2021 | 3 | 0.040 |
Why?
| | Risk Factors | 2 | 2017 | 10917 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2064 | 0.040 |
Why?
| | Omalizumab | 1 | 2020 | 43 | 0.040 |
Why?
| | Disease Progression | 2 | 2018 | 2865 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2018 | 2933 | 0.040 |
Why?
| | United States | 2 | 2018 | 16123 | 0.030 |
Why?
| | Rhinovirus | 1 | 2018 | 60 | 0.030 |
Why?
| | Cities | 1 | 2018 | 139 | 0.030 |
Why?
| | Seasons | 1 | 2020 | 538 | 0.030 |
Why?
| | Cytokines | 1 | 2025 | 2069 | 0.030 |
Why?
| | Climate | 1 | 2017 | 77 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2017 | 130 | 0.030 |
Why?
| | Adolescent | 3 | 2025 | 22573 | 0.030 |
Why?
| | Male | 4 | 2025 | 73003 | 0.030 |
Why?
| | Female | 4 | 2025 | 79035 | 0.030 |
Why?
| | Virus Diseases | 1 | 2017 | 216 | 0.030 |
Why?
| | Schools | 1 | 2018 | 449 | 0.030 |
Why?
| | Child, Preschool | 1 | 2010 | 11868 | 0.030 |
Why?
| | Immunization | 1 | 2016 | 375 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1270 | 0.020 |
Why?
| | Research | 1 | 2016 | 431 | 0.020 |
Why?
| | Precision Medicine | 1 | 2017 | 461 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1662 | 0.020 |
Why?
| | Steroid Hydroxylases | 1 | 2012 | 20 | 0.020 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2012 | 17 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 653 | 0.020 |
Why?
| | Interleukin-13 | 1 | 2012 | 146 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3170 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 14251 | 0.020 |
Why?
| | Microbiota | 1 | 2016 | 730 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1217 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4302 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3346 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4151 | 0.010 |
Why?
| | Adult | 2 | 2020 | 40872 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 8075 | 0.010 |
Why?
| | Middle Aged | 1 | 2012 | 36302 | 0.000 |
Why?
|
|
Searing's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|